The Evolving CDMO Landscape: Navigating a More Selective Future
The Contract Development and Manufacturing Organization (CDMO) sector, a pivotal engine in the pharmaceutical and biotechnology industries, is undergoing a profound transformation. The heady, often speculative, investment climate of 2021-2022, characterized by a “build it and they will come” mentality, has unequivocally ended. This shift is not a sign that the CDMO thesis is “broken,” […]